STMN2 mediates nuclear translocation of Smad2/3 and enhances TGFβ signaling by destabilizing microtubules to promote epithelial-mesenchymal transition in hepatocellular carcinoma
- 1 May 2021
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 506, 128-141
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
- China Hunan Provincial Science and Technology Department
- Ministry of Science and Technology of the People's Republic of China
This publication has 54 references indexed in Scilit:
- Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaborationBMC Medicine, 2012
- Siva1 suppresses epithelial–mesenchymal transition and metastasis of tumor cells by inhibiting stathmin and stabilizing microtubulesProceedings of the National Academy of Sciences, 2011
- Phosphorylation of SCG10/stathmin-2 determines multipolar stage exit and neuronal migration rateNature Neuroscience, 2011
- SCG10 Expression on Activation of Hepatic Stellate Cells Promotes Cell Motility Through Interference with MicrotubulesThe American Journal of Pathology, 2010
- Microtubule-binding agents: a dynamic field of cancer therapeuticsNature Reviews Drug Discovery, 2010
- Differential requirement for MEK/ERK and SMAD signaling in PAI-1 and CTGF expression in response to microtubule disruptionCellular Signalling, 2009
- Microtubule assembly, organization and dynamics in axons and dendritesNature Reviews Neuroscience, 2009
- EMT, the cytoskeleton, and cancer cell invasionCancer and Metastasis Reviews, 2009
- PPM1A Functions as a Smad Phosphatase to Terminate TGFβ SignalingCell, 2006
- PP2A Activation by β2-Adrenergic Receptor AgonistsJournal of Biological Chemistry, 2003